Key Takeaways ISRG is projected to report Q2 revenue of $2.35B and EPS of$1.92, with 15-17% procedure growth in 2025. Strong da Vinci 5 placements and Ion adoption likely drove ISRG's Q2, but bariatric weakness may offset gains. Tariff risks, elevated valuation, and global CapEx strain could limit ISRG upside despite solid fundamentals.Intuitive Surgical, Inc. (ISRG) is set to report second-quarter 2025 earnings on April 22. The Zacks Consensus Estimate for sales and earnings is pegged at $2.35 billion a ...